georgie18
Member Level
Re: None
Thursday, April 17, 2025 5:21:00 PM
Post#
679966
of 680043
XCUR...$10.40...🥳...Scaling in and bidding $8 range...Ran from $2 range to $27 on my previous alert...Although I was all out in the $15/$16 range...
Recent XCUR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:18:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2025 09:07:04 PM
- Exicure, Inc. Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/07/2025 09:00:00 PM
- New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting • GlobeNewswire Inc. • 11/03/2025 02:00:00 PM
- Exicure Highlights Recent Achievements and Near-term Strategic Priorities • GlobeNewswire Inc. • 10/06/2025 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2025 08:19:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/23/2025 08:07:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2025 08:19:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2025 03:52:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:21:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:11:36 PM
- Exicure, Inc. Reports Second Quarter 2025 Financial Results • Business Wire • 08/08/2025 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2025 08:49:55 PM
- Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements • Business Wire • 08/04/2025 08:37:00 PM
- Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant • Business Wire • 08/01/2025 08:01:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/22/2025 08:50:19 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/14/2025 03:40:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/27/2025 08:43:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 08:29:56 PM
- Exicure, Inc. Reports First Quarter 2025 Financial Results • Business Wire • 06/27/2025 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2025 08:47:29 PM
- Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q • Business Wire • 05/28/2025 08:58:00 PM
Isiah Thomas Marks Historic Milestone: First NBA Player With Majority Control of a Public Company • OWPC • Nov 6, 2025 12:23 PM
EVTV Takes Flight in Europe: U.S. Heavy-Lift Drones to Disrupt Traditional Vineyard Operations Across Italy • EVTV • Nov 6, 2025 8:19 AM
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment • AVAI • Nov 4, 2025 8:46 AM
ECGI Holdings Signs Binding $30 Million LOI to Acquire Licensed Mortgage Lender RezyFi • ECGI • Nov 3, 2025 8:30 AM
One World Products Secures OEM Approval for Cellulose Fiber-Filled Masterbatch for Future Vehicle Programs • OWPC • Nov 3, 2025 8:15 AM
From Explorer to Producer: The Most Compelling Mining Window • ABMBF • Oct 30, 2025 9:00 AM
